Second AGI YII Webinar Series
The topic of the second webinar series of the Ataxia Global Young Investigator Initiative is
iScience: AGI YII Webinar Series on Hot Topics
Explore Your Future in Ataxia Research
The webinars will start in July 2023.
Target audience: young investigators in the ataxia field, who we hope to give a head start in their career by introducing important aspects of various research topics. Of course, anyone who is interested is welcome to attend!
Registration: The registration is now open.
Webinar 1: Clinical scales for ataxia: current state and ongoing developments
Speakers: Thomas Klockgether (Bonn, Germany) - WG1: Clinical outcomes and registries
Tuesday, 11 July 2023, 3-4 pm CEST
There are a number of clinical scales that are currently used for assessment of ataxia, among them the Scale for the Assessment and Rating of Ataxia (SARA). Although these scales are widely used and have numerous advantages, they also have weaknesses. Critique of SARA concerns lack of anchoring in patient experience, questionable meaningfulness of single items and score changes, limited sensitivity to change, and variable scoring ranges of single items.
The webinar will present the current state of available ataxia scales and discuss options for development of new and modification of existing scales.
Webinar 2: Deep-Learning in NeuroImaging
Speaker: Martin Reuter (DZNE Bonn, Germany) - WG3: MRI Biomarkers
Monday, 17 July 2023, 3-4 pm CEST
Increasing availability of medical imaging data with respect to quantity, resolution and modalities, pose challenges to traditional processing and analysis methods. Large cohort studies such as the ADNI, Human Connectome Project, UK Biobank, Rhineland study etc. collect rich data on 10-thousands of individuals. In order to investigate etiology, progression, treatment, risk and preserving factors of neurodegenerative diseases we need descriptive features, obtained by efficient automatic processing methods. Traditional approaches that depend on non-rigid atlas registration and segmentation, however, can take many hours up to a day for a single image, and are, thus, not efficient enough to handle big data or provide quick results.
We develop fast AI methods for large multimodal datasets using deep learning that can process images in minutes rather than hours. With FastSurfer we have introduced a method that can achieve full brain segmentation in under 1 minute, with extensions to fat segmentation in Dixon MRI, olfactory bulb segmentation as well as cerebellum and hypothalamus sub-segmentations. Furthermore, we push deep-learning method development beyond a fixed image grid in our recent multi-resolution FastSurferVINN approach and operate on geometric shapes (no image grid) for cortical parcellations. Furthermore, advanced deep-learning approaches can help speed-up diffusion MRI acquisition significantly at improved SNR - a first step towards moving high angular resolution dMRI into clinical applications.
no video/slides available
Webinar 3: Repeat-expansions in ataxias: direct sequencing, detection by short-read WES/WGS vs long-read WGS, and novel forms
Speakers: Matthis Synofzik (Tübingen, Germany), Stephan Zuchner (Miami, USA), Matt Danzi (Miami, USA), Brent Fogel (Los Angeles, USA), David Pellerin (London, UK) - WG6: Next-generation genomics and platforms
Tuesday, 12 September 2023, 8-9 pm CEST
This webinar will focus on the genetics of coding and non-coding repeat expansions in ataxias. It will start with a short overview introduction into the different forms and their relative frequencies. The main focus will be on a presentation and comparative discussion of the different - and in particular the most recent - genetic sequencing strategies and their respective strengths and limitations to detect coding vs non-coding ataxia repeat expansions: direct repeat sequencing/fragment analysis, whole exome-sequencing (WES), short-read whole genome sequencing (SR-WGS), and long-read whole genome sequencing (LR-WGS). The webinar will be completed by presenting the most recently identified, novel forms of repeat expansions (RFC1, SCA27B) in more depth, including their genetic assessment methods, with both of them accounting for a substantial share of so far unexplained ataxia patients.
Webinar 4: Quantitative Gait and Balance Outcomes for Ataxia Trials
Speakers: Fay Horak (Oregon Health and Science University, USA); Winfried Ilg (University of Tuebingen, Germany) - by WG4 Digital-motor biomarkers
Tuesday, 19 September 2023, 5-6pm CEST
With disease-modifying drugs on the horizon for degenerative ataxias, ecologically valid, finely granulated, digital health measures are highly warranted to augment clinical and patient-reported outcome measures. Gait and balance disturbances most often present as the first signs of degenerative cerebellar ataxia and are the most reported disabling features in disease progression. Thus, digital gait and balance measures constitute promising and relevant performance outcomes for interventional studies.
This presentation will review evidence for the sensitivity and validity of digital gait and balance measures to ataxia severity in cross-sectional and longitudinal studies, propose a consensus protocol for establishing gait and balance metrics in natural history studies and clinical trials, and discuss relevant issues for their use as performance outcomes in clinical trials.
Webinar 5: Future projects for biomarker group
Speakers: David Mengel (Tübingen, Germany), Puneet Opal (Chicago, USA), Filippo Santorelli (Pisa, Italy) - WG2 Molecular biomarkers & biosampling
Tuesday, 24 October 2023, 5-6pm CEST
The webinar will focus on overview on NFL use in inherited ataxias and on remote collection methodologies such as those using self sampling on DBS.
First AGI YII Webinar Series
The first webinar series took place in 2022. Here, you can find the information on the series and slides/videos:
Target audience: young investigators in the ataxia field
Recordings: Please find the links to the recorded webinars in the table below.
|Tuesday 17 May 2022
|Fluid biomarkers for trial readiness in ataxia||David Mengel, Puneet Opal, Filippo Santorelli||University of Tübingen, Germany; Northwestern University, Chicago, USA; IRCCS Fondazione Stella Maris, Pisa, Italy||WG2: Molecular biomarkers & biosampling||Available here
|Tuesday 29 March 2022
|Digital-motor biomarkers in ataxia: introduction and overview across motor domains||Adam Vogel||The University of Melbourne, Australia||WG4: Digital-motor biomarkers||Available here
|Tuesday 22 February 2022
|Standard clinical assessment in ataxia||Thomas Klockgether||University Hospital Bonn, Germany||WG1: Clinical outcomes and registries||Available here
|Tuesday 18 January 2022
|NGS analysis in ataxias: what it is and how it is done||Andrea Nemeth, Matthis Synofzik, Stephan Zuchner||University of Oxford, University of Tübingen, University of Miami||WG6: Next-generation genomics and platforms||Available here||Matthis Synofzik & Stephan Zuchner|
|Tuesday 14 December 2021
|Magnetic resonance imaging in clinical care and research of ataxias||Sirio Cocozza, Gülin Öz||University of Minnesota, University of Naples "Federico II"||WG3: MRI Biomarkers||Available here||Sirio Cocozza|